S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.38%) $966.30
USD/EUR
(-0.36%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

Actualizaciones en tiempo real para Smith & Nephew SNATS Inc. [SNN]

Bolsa: NYSE Sector: Healthcare Industria: Medical - Devices
Última actualización3 may 2024 @ 16:00

1.39% $ 24.78

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):
Profile picture for Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures...

Stats
Volumen de hoy 1.06M
Volumen promedio 959 743
Capitalización de mercado 10.80B
EPS $0 ( 2024-02-27 )
Próxima fecha de ganancias ( $0 ) 2024-08-01
Last Dividend $0.288 ( 2023-10-05 )
Next Dividend $0 ( N/A )
P/E 41.30
ATR14 $0.0100 (0.04%)

Volumen Correlación

Largo: -0.17 (neutral)
Corto: 0.78 (moderate)
Signal:(56.487) Neutral

Smith & Nephew SNATS Inc. Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Smith & Nephew SNATS Inc. Correlación - Moneda/Commodity

The country flag 0.46
( neutral )
The country flag 0.84
( strong )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.51
( weak negative )
The country flag 0.59
( weak )

Smith & Nephew SNATS Inc. Finanzas

Annual 2023
Ingresos: $5.55B
Beneficio Bruto: $3.70B (66.70 %)
EPS: $0.600
FY 2023
Ingresos: $5.55B
Beneficio Bruto: $3.70B (66.70 %)
EPS: $0.600
FY 2022
Ingresos: $5.22B
Beneficio Bruto: $3.70B (70.85 %)
EPS: $0.510
FY 2021
Ingresos: $5.21B
Beneficio Bruto: $3.67B (70.40 %)
EPS: $1.196

Financial Reports:

No articles found.

Smith & Nephew SNATS Inc. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.288
(N/A)
$0
(N/A)
$0.462
(N/A)
$0
(N/A)
$0
(N/A)
$0.288
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Smith & Nephew SNATS Inc. Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.49 - Stable (10.24%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.139 2000-05-04
Last Dividend $0.288 2023-10-05
Next Dividend $0 N/A
Payout Date 2023-11-01
Next Payout Date N/A
# dividends 48 --
Total Paid Out $10.43 --
Avg. Dividend % Per Year 1.50% --
Score 4.34 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.49
Div. Directional Score 7.54 --
Next Divdend (Est)
(2024-09-30)
$0.288 Estimate 7.53 %
Dividend Stability
0.30 Poor
Dividend Score
4.34
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
2000 $0.194 2.88%
2001 $0.146 1.58%
2002 $0.154 1.28%
2003 $0.169 1.36%
2004 $0.184 1.10%
2005 $0.194 0.96%
2006 $0.204 1.08%
2007 $0.223 1.07%
2008 $0.247 1.07%
2009 $0.271 2.08%
2010 $0.299 1.45%
2011 $0.328 1.56%
2012 $0.414 2.12%
2013 $0.532 2.39%
2014 $0.560 1.98%
2015 $0.608 1.69%
2016 $0.626 1.80%
2017 $0.616 2.05%
2018 $0.734 2.10%
2019 $0.728 2.00%
2020 $0.750 1.55%
2021 $0.750 1.75%
2022 $0.750 2.14%
2023 $0.750 2.75%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50
ORC Dividend Royal 2023-11-29 Monthly 12 9.23% 8.50
SRV Dividend Royal 2023-12-04 Monthly 18 7.53% 8.50
NCZ Dividend Royal 2024-02-09 Monthly 22 7.79% 8.50
VGI Dividend Royal 2024-02-09 Monthly 13 7.36% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.04751.5009.0510.00[0 - 0.5]
returnOnAssetsTTM0.02631.2009.1210.00[0 - 0.3]
returnOnEquityTTM0.05021.500-0.553-0.830[0.1 - 1]
payoutRatioTTM1.247-1.00010.00-10.00[0 - 1]
currentRatioTTM1.7750.8006.134.90[1 - 3]
quickRatioTTM0.6790.800-0.709-0.567[0.8 - 2.5]
cashRatioTTM0.1331.500-0.372-0.558[0.2 - 2]
debtRatioTTM0.294-1.5005.09-7.64[0 - 0.6]
interestCoverageTTM5.491.0009.089.08[3 - 30]
operatingCashFlowPerShareTTM1.3842.009.5410.00[0 - 30]
freeCashFlowPerShareTTM0.4122.009.7910.00[0 - 20]
debtEquityRatioTTM0.564-1.5007.75-10.00[0 - 2.5]
grossProfitMarginTTM0.6881.0001.8621.862[0.2 - 0.8]
operatingProfitMarginTTM0.1371.0009.259.25[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2051.0009.979.97[0.2 - 2]
assetTurnoverTTM0.5530.8009.647.72[0.5 - 2]
Total Score10.60

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM40.621.0006.000[1 - 100]
returnOnEquityTTM0.05022.50-0.356-0.830[0.1 - 1.5]
freeCashFlowPerShareTTM0.4122.009.8610.00[0 - 30]
dividendYielPercentageTTM3.071.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.3842.009.5410.00[0 - 30]
payoutRatioTTM1.2471.50010.00-10.00[0 - 1]
pegRatioTTM-1.5901.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1091.0009.770[0.1 - 0.5]
Total Score4.49

Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico